This chapter explores the development and approval of new medications for postpartum depression, including Brexanalone and Zaranalone. It discusses the positive effects of these medications in improving depression symptoms quickly and addresses the barriers to accessing effective treatments for postpartum depression.
The FDA’s approval of a new pill that treats postpartum depression could be yet another signal that we are living in a golden age of medicine.
This episode was produced by Jon Ehrens, edited by Amina Al-Sadi, fact-checked by Laura Bullard, engineered by Patrick Boyd, and hosted by Sean Rameswaram.
Transcript at vox.com/todayexplained
Support Today, Explained by making a financial contribution to Vox! bit.ly/givepodcasts
Learn more about your ad choices. Visit podcastchoices.com/adchoices